Overview

Safety Study of Nicotinamide to Treat Alzheimer's Disease

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nicotinamide, or vitamin B3, is safe and effective in the treatment of Alzheimer's disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of California, Irvine
Collaborator:
Alzheimer's Association
Treatments:
Niacin
Niacinamide
Nicotinic Acids